Product Information

VERAPAMIL SR 120 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $2.3305 per EA under NDC 52536088001. Its NADAC has been published 76 times since Mar 12, 2025.

FDA first approved this application on May 29, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VERAPAMIL SR 120 MG CAPSULE

verapamil hydrochloride
$2.3305per EA

Strength

120 mg/1

NDC

52536088001

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

VERAPAMIL HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA019614

FDA Approved

5/29/1990

TE Code

AB

On Market Since

5/29/1990

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for VERAPAMIL SR 120 MG CAPSULE has been published 76 times since Mar 12, 2025, and over the history we have for it it has risen 111.2%. The table below summarizes its recorded NADAC range and movement.

Current price$2.3305 per EA
All-time high$2.3305 (Aug 19, 2026)
All-time low$0.9946 (Aug 20, 2025)
52-week high$2.3305
52-week low$0.9946
Median price$1.2959
Average price$1.3310
Largest weekly change+37.8% (Aug 19, 2026)
Weeks tracked76
Tracking sinceMar 12, 2025

Price History

1W

+37.8%

1M

+79.7%

3M

+79.8%

6M

+33.6%

1Y

+134.3%

3Y

N/A

5Y

N/A

All

+111.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of VERAPAMIL SR 120 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 120 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $2.3305 per EA (NDC 52536088001), effective Aug 19, 2026.

How has the price of VERAPAMIL SR 120 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for VERAPAMIL SR 120 MG CAPSULE has risen 111.2%. It has been tracked across 76 weekly CMS publications since Mar 12, 2025.

What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 120 MG CAPSULE?

Since Mar 12, 2025, the NADAC for VERAPAMIL SR 120 MG CAPSULE has ranged from a low of $0.9946 (Aug 20, 2025) to a high of $2.3305 (Aug 19, 2026), with a median of $1.2959 per EA.

Are there cheaper alternatives to VERAPAMIL SR 120 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VERAPAMIL SR 120 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures VERAPAMIL SR 120 MG CAPSULE?

VERAPAMIL SR 120 MG CAPSULE (NDC 52536088001) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.